Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The medication hasnt changed
If weight remains stable, appetite stays controlled, and metabolic markers remain improved, continue reducing
Besides, producing biologic drugs involves highly specialized infrastructure for production along with stringent quality standards
The PP analysis set comprised all patients in the FAS who have not violated any inclusion criteria, have not fulfilled any exclusion criteria, have a valid baseline A1C measurement and were exposed to treatment and have at least 1 valid A1C measurement while on treatment without rescue medication at or after week 14
Clinical studies are ongoing globally, and Anifrolumab is under regulatory review in the EU and Japan (132)
Archived from the original on February 28, 2009
US$ 22.03
US$ 24.01
US$ 21.60
US$ 28.95
US$ 20.38
US$ 20.63
